| Literature DB >> 34917171 |
Hatem H Allam1, Alaa Shafie2, Amal F Gharib2, Ahmad El Askary2, Mazen Almehmadi2, Tarek Alsayad3, Ahmed M Alziyadi4, Lamiaa K Elsayyad1.
Abstract
BACKGROUND: Children with Down's syndrome are more liable to vitamin D deficiency. Treating this deficiency with supplements is associated with the risk of intoxication. AIM: The study is aimed at comparing the effect of two exercise intensities on the modulation of vitamin D and parathormone levels in children with DS.Entities:
Year: 2021 PMID: 34917171 PMCID: PMC8670939 DOI: 10.1155/2021/7424857
Source DB: PubMed Journal: Appl Bionics Biomech ISSN: 1176-2322 Impact factor: 1.781
Figure 1Flowchart showing the children who participated in the study.
The sequence of treadmill aerobic exercises (T-AE) for GI and GII.
| Week | High intensity | Moderate intensity | Time (min) |
|---|---|---|---|
| 1, 2 | 70% | 50% | 20 |
| 3, 4 | 75% | 55% | 25 |
| 5, 6 | 80% | 60% | 30 |
| 7, 8 | 85% | 65% | 35 |
| 9, 10 | 90% | 67% | 40 |
| 11, 12 | 90% | 67% | 40 |
Bonferroni pairwise comparisons for Vit D (within subjects and between subjects).
| Vit D ng/ml (M ± SD) | MD (within subjects) | ||||||
|---|---|---|---|---|---|---|---|
| Pre | Post1 | Post2 | Prepost1 | Sig. | Prepost2 | Sig. | |
| GI | 17.74 ± 5.38 | 22.72 ± 4.67 | 24.47 ± 4.29 | -4.98 | .013∗ | -6.732 | .000∗ |
| GII | 17.05 ± 5.26 | 19.62 ± 6.59 | 20.24 ± 3.93 | -2.575 | .383 | -3.189 | .082 |
| MD (between subjects) GI-GII | .691 | 3.1 | 4.24 | ||||
| Sig. | .669 | .079 | .001∗ | ||||
M: mean; SD: standard deviation; MD: mean difference. ∗Significant difference.
Bonferroni pairwise comparisons for PTH (within subjects and between subjects).
| PTH pmol/L (M ± SD) | MD (within subjects) | ||||||
|---|---|---|---|---|---|---|---|
| Pre | Post1 | Post2 | Prepost1 | Sig. | Prepost2 | Sig. | |
| GI | 50.96 ± 9.08 | 46.82 ± 9.29 | 37.40 ± 9.18 | 4.14 | .396 | 13.56 | .000∗ |
| GII | 49.07 ± 9.40 | 44.25 ± 6.23 | 43.62 ± 6.41 | 4.82 | .244 | 5.45 | .171 |
| MD (between subjects) GI-GII | 1.89 | 2.56 | -6.22 | ||||
| Sig. | .501 | .289 | .013∗ | ||||
M: mean; SD: standard deviation; MD: mean difference. ∗Significant difference.
| Multivariate test | |||||
|---|---|---|---|---|---|
| Value |
| Hypothesis df | Error df | Sig. | |
| Wilks' lambda | .912 | .731 | 5.000 | 38.000 | .604 |
| Bonferroni pairwise comparisons | ||||
|---|---|---|---|---|
| Demographic variables | GI M ± SD | GII M ± SD | MD (GI-GII) | Sig. |
| Sun (h/week) | 15.68 ± 3.85 | 16.32 ± 3.06 | -.64 | .547 |
| Vit D intake (mg/day) | 104.86 ± 13.93 | 103.41 ± 14.9 | 1.46 | .740 |
| Age (year) | 10.27 ± 1.45 | 10.18 ± 1.47 | .091 | .837 |
| PA | 4.91 ± .92 | 5.45 ± .91 | -.55 | .055 |
| BMI percentile | 69.50 ± 5.93 | 69.09 ± 6.04 | .41 | .822 |
M: mean; SD: standard deviation; MD: mean difference; PA: physical activity; BMI: body mass index.
| Tests of within subjects' effects (multivariate) | ||||||
|---|---|---|---|---|---|---|
| Source | Test | Value |
| Hypothesis df | Error df | Sig. |
| Hormonal level | Wilks' lambda | .604 | 11.892 | 4.000 | 166.000 | .000 |
| Hormonal level ∗ group | Wilks' lambda | .885 | 2.607 | 4.000 | 166.000 | .038 |
| Tests of within subjects' effects (univariate) | |||||||
|---|---|---|---|---|---|---|---|
| Source | Measure | Test | Type III sum of squares | df | Mean square |
| Sig. |
| Hormonal level | PTH | Huynh-Feldt | 1988.33 | 1.83 | 1086.47 | 14.43 | .000 |
| Vit D | 590.76 | 2.00 | 295.38 | 11.49 | .000 | ||
| Hormonal level ∗ group | PTH | Huynh-Feldt | 525.46 | 1.83 | 287.12 | 3.815 | .030 |
| Vit D | 72.02 | 2.00 | 36.01 | 1.401 | .252 | ||
| Tests of between subjects' effects | ||||||
|---|---|---|---|---|---|---|
| Source | Measure | Type III sum of squares | df | Mean square |
| Sig. |
| Group | PTH | 11.422 | 1 | 11.422 | .156 | .695 |
| Vit D | 236.189 | 1 | 236.189 | 8.955 | .005 | |
PTH: parathormone; Sig.: significance; df: degree of freedom.